Genelux (GNLX) Net Equity Issued and Repurchased (2023 - 2026)

Genelux's (GNLX) quarterly Net Equity Issued and Repurchased came in at $18.5 million in Q1 2026, up 93.92% year-on-year from $9.6 million in Q1 2025, and up 93.92% quarter-over-quarter from $9.6 million in Q1 2025.

Genelux (GNLX) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends

Genelux's Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at $18.5 million for Q1 2026.

  • On a quarterly basis, Net Equity Issued and Repurchased rose 93.92% year-over-year to $18.5 million in Q1 2026; TTM through Mar 2026 was $18.5 million, a 93.61% increase from a year earlier, with the FY2025 full-year figure at $9.6 million, down 65.5% from the prior year.
  • Net Equity Issued and Repurchased advanced to $18.5 million in Q1 2026 per GNLX's latest filing, from $9.6 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $18.5 million in Q1 2026 and bottomed at $15000.0 in Q4 2024.
  • The 4-year median for Net Equity Issued and Repurchased is $8.3 million (2023), against an average of $8.9 million.
  • Biggest YoY gain for Net Equity Issued and Repurchased was 93.92% in 2026; the steepest drop was 93.92% in 2026.
  • Year by year, Net Equity Issued and Repurchased stood at $3.5 million in 2023, then sank by 99.57% to $15000.0 in 2024, then jumped by 63586.67% to $9.6 million in 2025, then surged by 93.92% to $18.5 million in 2026.
  • Per Business Quant, the three latest GNLX Net Equity Issued and Repurchased figures stand at $18.5 million (Q1 2026), $9.6 million (Q1 2025), and $15000.0 (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 141.90 Mn
10 Genelux 129.36 Mn 129.36 Mn - 18.53 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.53 Mn
Mar 31, 2026 18.53 Mn
Mar 31, 2025 9.55 Mn
Mar 31, 2025 9.55 Mn
Dec 31, 2024 15,000.00
Dec 31, 2024 15,000.00
Sep 30, 2023 3.50 Mn
Sep 30, 2023 3.50 Mn
Jun 30, 2023 7.14 Mn
Jun 30, 2023 7.14 Mn
Mar 31, 2023 14.50 Mn
Mar 31, 2023 14.50 Mn